Cargando…

Comment on Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947

Detalles Bibliográficos
Autores principales: Lissing, Mattias, Vassiliou, Daphne, Harper, Pauline, Sardh, Eliane, Wahlin, Staffan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913564/
https://www.ncbi.nlm.nih.gov/pubmed/36765753
http://dx.doi.org/10.3390/cancers15030795
_version_ 1784885458062278656
author Lissing, Mattias
Vassiliou, Daphne
Harper, Pauline
Sardh, Eliane
Wahlin, Staffan
author_facet Lissing, Mattias
Vassiliou, Daphne
Harper, Pauline
Sardh, Eliane
Wahlin, Staffan
author_sort Lissing, Mattias
collection PubMed
description
format Online
Article
Text
id pubmed-9913564
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99135642023-02-11 Comment on Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947 Lissing, Mattias Vassiliou, Daphne Harper, Pauline Sardh, Eliane Wahlin, Staffan Cancers (Basel) Comment MDPI 2023-01-28 /pmc/articles/PMC9913564/ /pubmed/36765753 http://dx.doi.org/10.3390/cancers15030795 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Comment
Lissing, Mattias
Vassiliou, Daphne
Harper, Pauline
Sardh, Eliane
Wahlin, Staffan
Comment on Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947
title Comment on Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947
title_full Comment on Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947
title_fullStr Comment on Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947
title_full_unstemmed Comment on Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947
title_short Comment on Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947
title_sort comment on ramai et al. risk of hepatocellular carcinoma in patients with porphyria: a systematic review. cancers 2022, 14, 2947
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913564/
https://www.ncbi.nlm.nih.gov/pubmed/36765753
http://dx.doi.org/10.3390/cancers15030795
work_keys_str_mv AT lissingmattias commentonramaietalriskofhepatocellularcarcinomainpatientswithporphyriaasystematicreviewcancers2022142947
AT vassilioudaphne commentonramaietalriskofhepatocellularcarcinomainpatientswithporphyriaasystematicreviewcancers2022142947
AT harperpauline commentonramaietalriskofhepatocellularcarcinomainpatientswithporphyriaasystematicreviewcancers2022142947
AT sardheliane commentonramaietalriskofhepatocellularcarcinomainpatientswithporphyriaasystematicreviewcancers2022142947
AT wahlinstaffan commentonramaietalriskofhepatocellularcarcinomainpatientswithporphyriaasystematicreviewcancers2022142947